Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of fedratinib on the pharmacokinetics of transporter probe substrates using a cocktail approach. | Cancer Chemother Pharmacol | 2021 | 34477937 | PubTator, text mining | PubMed |
| Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions. | Drugs Context | 2021 | 34457015 | PubTator, text mining | PubMed |
| In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN). | Pharmaceuticals (Basel) | 2021 | 34451808 | PubTator, text mining | PubMed |
| Genetic Association of Solute Carrier Transporter Gene Variants with Metformin Response. | Balkan J Med Genet | 2021 | 34447659 | PubTator, text mining | PubMed |
| In Vitro Nephrotoxicity Studies of Established and Experimental Platinum-Based Compounds. | Biomedicines | 2021 | 34440237 | PubTator, text mining | PubMed |
| Uptake of Biotinylated Spermine in Astrocytes: Effect of Cx43 siRNA, HIV-Tat Protein and Polyamine Transport Inhibitor on Polyamine Uptake. | Biomolecules | 2021 | 34439853 | PubTator, text mining | PubMed |
| Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine. | Clin Pharmacokinet | 2021 | 34435310 | PubTator, text mining | PubMed |
| Tenofovir alafenamide nephrotoxicity: a case report and literature review. | AIDS Res Ther | 2021 | 34419091 | PubTator, text mining | PubMed |
| Efficacy and safety of arimoclomol in Niemann-Pick disease type C: Results from a double-blind, randomised, placebo-controlled, multinational phase 2/3 trial of a novel treatment. | J Inherit Metab Dis | 2021 | 34418116 | PubTator, text mining | PubMed |
| Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity. | Am J Audiol | 2021 | 34415784 | PubTator, text mining | PubMed |
| Multi-omics profiling: the way towards precision medicine in metabolic diseases. | J Mol Cell Biol | 2021 | 34406397 | PubTator, text mining | PubMed |
| Preferential Cochleotoxicity of Cisplatin. | Front Neurosci | 2021 | 34381329 | PubTator, text mining | PubMed |
| Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis. | EMBO Mol Med | 2021 | 34378323 | PubTator, text mining | PubMed |
| Inhibition of the Hepatic Uptake of 99mTc-Tetrofosmin Using an Organic Cation Transporter Blocker. | Pharmaceutics | 2021 | 34371764 | PubTator, text mining | PubMed |
| Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients. | Front Oncol | 2021 | 34367956 | PubTator, text mining | PubMed |
| Solute carrier family 12 member 8 (SLC12A8) is a potential biomarker and related to tumor immune cell infiltration in bladder cancer. | Bioengineered | 2021 | 34365894 | PubTator, text mining | PubMed |
| Development, validation, and application of an LC-MS/MS method for the determination of the AXL/FLT3 inhibitor gilteritinib in mouse plasma. | J Chromatogr B Analyt Technol Biomed Life Sci | 2021 | 34365291 | PubTator, text mining | PubMed |
| Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments. | Int J Mol Sci | 2021 | 34361037 | PubTator, text mining | PubMed |
| Identification of an IL-22-Dependent Gene Signature as a Pharmacodynamic Biomarker. | Int J Mol Sci | 2021 | 34360971 | PubTator, text mining | PubMed |
| Differential Serotonin Uptake Mechanisms at the Human Maternal-Fetal Interface. | Int J Mol Sci | 2021 | 34360573 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=37